Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Managers of Molecular Imaging Laboratories (MOMIL) Interest Group.

Nickels ML, Pagel MD.

Mol Imaging Biol. 2017 Jun;19(3):332-335. doi: 10.1007/s11307-017-1075-9.

PMID:
28299547
2.

Optimized Translocator Protein Ligand for Optical Molecular Imaging and Screening.

Li J, Smith JA, Dawson ES, Fu A, Nickels ML, Schulte ML, Manning HC.

Bioconjug Chem. 2017 Apr 19;28(4):1016-1023. doi: 10.1021/acs.bioconjchem.6b00711. Epub 2017 Feb 13.

PMID:
28156095
3.

Evaluation of TSPO PET Ligands [18F]VUIIS1009A and [18F]VUIIS1009B: Tracers for Cancer Imaging.

Tang D, Li J, Buck JR, Tantawy MN, Xia Y, Harp JM, Nickels ML, Meiler J, Manning HC.

Mol Imaging Biol. 2017 Aug;19(4):578-588. doi: 10.1007/s11307-016-1027-9.

PMID:
27853987
4.

Utility of [18F]FSPG PET to Image Hepatocellular Carcinoma: First Clinical Evaluation in a US Population.

Kavanaugh G, Williams J, Morris AS, Nickels ML, Walker R, Koglin N, Stephens AW, Washington MK, Geevarghese SK, Liu Q, Ayers D, Shyr Y, Manning HC.

Mol Imaging Biol. 2016 Dec;18(6):924-934.

PMID:
27677886
5.

New structure-activity relationships of N-acetamide substituted pyrazolopyrimidines as pharmacological ligands of TSPO.

Li J, Schulte ML, Nickels ML, Manning HC.

Bioorg Med Chem Lett. 2016 Aug 1;26(15):3472-7. doi: 10.1016/j.bmcl.2016.06.041. Epub 2016 Jun 16.

6.

Clinicians' perceptions of rationales for rehabilitative exercise in a critical care setting: A cross-sectional study.

Nickels M, Aitken LM, Walsham J, Watson L, McPhail S.

Aust Crit Care. 2017 Mar;30(2):79-84. doi: 10.1016/j.aucc.2016.03.003. Epub 2016 Apr 19.

PMID:
27105830
7.

Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer.

Hassanein M, Hight MR, Buck JR, Tantawy MN, Nickels ML, Hoeksema MD, Harris BK, Boyd K, Massion PP, Manning HC.

Mol Imaging Biol. 2016 Feb;18(1):18-23. doi: 10.1007/s11307-015-0862-4.

8.

Incidence of primary hypertension in a population-based cohort of HIV-infected compared with non-HIV-infected persons and the effect of combined antiretroviral therapy.

Tripathi A, Jerrell JM, Skelton TN, Nickels MA, Duffus WA.

J Am Soc Hypertens. 2015 May;9(5):351-7. doi: 10.1016/j.jash.2015.01.007. Epub 2015 Jan 19.

PMID:
25766497
9.

Detection of breast cancer microcalcification using (99m)Tc-MDP SPECT or Osteosense 750EX FMT imaging.

Felix DD, Gore JC, Yankeelov TE, Peterson TE, Barnes S, Whisenant J, Weis J, Shoukouhi S, Virostko J, Nickels M, McIntyre JO, Sanders M, Abramson V, Tantawy MN.

Nucl Med Biol. 2015 Mar;42(3):269-73. doi: 10.1016/j.nucmedbio.2014.11.010. Epub 2014 Dec 6.

10.

High-yielding, automated production of 3'-deoxy-3'-[(18)F]fluorothymidine using a modified Bioscan Coincidence FDG reaction module.

Cheung YY, Nickels ML, McKinley ET, Buck JR, Manning HC.

Appl Radiat Isot. 2015 Mar;97:47-51. doi: 10.1016/j.apradiso.2014.11.011. Epub 2014 Dec 15.

11.

Expert consensus and recommendations on safety criteria for active mobilization of mechanically ventilated critically ill adults.

Hodgson CL, Stiller K, Needham DM, Tipping CJ, Harrold M, Baldwin CE, Bradley S, Berney S, Caruana LR, Elliott D, Green M, Haines K, Higgins AM, Kaukonen KM, Leditschke IA, Nickels MR, Paratz J, Patman S, Skinner EH, Young PJ, Zanni JM, Denehy L, Webb SA.

Crit Care. 2014 Dec 4;18(6):658. doi: 10.1186/s13054-014-0658-y. Review.

12.
13.
14.

PET radiotracer [¹⁸F]-P6 selectively targeting COX-1 as a novel biomarker in ovarian cancer: preliminary investigation.

Perrone MG, Malerba P, Uddin J, Vitale P, Panella A, Crews BC, Daniel CK, Ghebreselasie K, Nickels M, Tantawy MN, Manning HC, Marnett LJ, Scilimati A.

Eur J Med Chem. 2014 Jun 10;80:562-568. doi: 10.1016/j.ejmech.2014.04.074. Epub 2014 Apr 29.

15.

A peptide-based positron emission tomography probe for in vivo detection of caspase activity in apoptotic cells.

Hight MR, Cheung YY, Nickels ML, Dawson ES, Zhao P, Saleh S, Buck JR, Tang D, Washington MK, Coffey RJ, Manning HC.

Clin Cancer Res. 2014 Apr 15;20(8):2126-35. doi: 10.1158/1078-0432.CCR-13-2444. Epub 2014 Feb 26.

16.

Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging.

Tang D, McKinley ET, Hight MR, Uddin MI, Harp JM, Fu A, Nickels ML, Buck JR, Manning HC.

J Med Chem. 2013 Apr 25;56(8):3429-33. doi: 10.1021/jm4001874. Epub 2013 Apr 3.

17.

Convergent synthesis and evaluation of (18)F-labeled azulenic COX2 probes for cancer imaging.

Nolting DD, Nickels M, Tantawy MN, Yu JY, Xie J, Peterson TE, Crews BC, Marnett L, Gore JC, Pham W.

Front Oncol. 2013 Jan 3;2:207. doi: 10.3389/fonc.2012.00207. eCollection 2012.

18.

Investigating a cluster of vulvar cancer in young women: a cross-sectional study of genital human papillomavirus prevalence.

Rumbold AR, Tan SE, Condon JR, Taylor-Thomson D, Nickels M, Tabrizi SN, Davy ML, O'Brien MM, Connors CM, Zardawi I, Stankovich J, Garland SM.

BMC Infect Dis. 2012 Oct 5;12:243. doi: 10.1186/1471-2334-12-243.

19.

Molecular imaging probe development: a chemistry perspective.

Nolting DD, Nickels ML, Guo N, Pham W.

Am J Nucl Med Mol Imaging. 2012 Jul 10;2(3):273-306.

20.

Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide.

Tang D, Hight MR, McKinley ET, Fu A, Buck JR, Smith RA, Tantawy MN, Peterson TE, Colvin DC, Ansari MS, Nickels M, Manning HC.

J Nucl Med. 2012 Feb;53(2):287-94. doi: 10.2967/jnumed.111.095653. Epub 2012 Jan 17.

Supplemental Content

Loading ...
Support Center